NZ707329A - Tetracycline compositions - Google Patents
Tetracycline compositionsInfo
- Publication number
- NZ707329A NZ707329A NZ707329A NZ70732911A NZ707329A NZ 707329 A NZ707329 A NZ 707329A NZ 707329 A NZ707329 A NZ 707329A NZ 70732911 A NZ70732911 A NZ 70732911A NZ 707329 A NZ707329 A NZ 707329A
- Authority
- NZ
- New Zealand
- Prior art keywords
- compositions
- divalent
- disclosed
- dimethylamino
- tetracycline antibiotic
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33410610P | 2010-05-12 | 2010-05-12 | |
US39230410P | 2010-10-12 | 2010-10-12 | |
NZ60378411 | 2011-05-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ707329A true NZ707329A (en) | 2016-09-30 |
Family
ID=56989721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ707329A NZ707329A (en) | 2010-05-12 | 2011-05-12 | Tetracycline compositions |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ707329A (en) |
-
2011
- 2011-05-12 NZ NZ707329A patent/NZ707329A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA105229C2 (en) | Pharmaceutical formulation | |
IL203448A (en) | Azabiphenylaminobenzoic acid derivatives for use in the treatment or prevention of a pathological condition or disease susceptible to amelioration by inhibition of dhodh and pharmaceutical compositions comprising them | |
MX347544B (en) | Polycyclic lpa1 antagonist and uses thereof. | |
WO2010108074A3 (en) | Inhibitors of pi3 kinase | |
MX2010006799A (en) | Benzofuropyrimidinones as protein kinase inhibitors. | |
NZ601689A (en) | Crystalline forms for 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said forms | |
IN2014MN02106A (en) | ||
MY164274A (en) | Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof | |
MX2016006197A (en) | Formulations of azaindole compounds. | |
MX2009005413A (en) | Crystalline forms of zoledronic acid. | |
WO2011058027A3 (en) | N-9-substituted purine compounds, compositions and methods of use | |
IN2012DN00765A (en) | ||
IN2012DN02502A (en) | ||
TN2015000356A1 (en) | Bicyclic compounds | |
MY173491A (en) | Therapeutic or prophylactic agent for biliary tract diseases | |
MX2012001691A (en) | Orally disintegrating compositions of linaclotide. | |
AU2010275640A8 (en) | Benzoquinolizinium salt derivatives as anticancer agents | |
TN2012000105A1 (en) | Spirolactam derivatives and uses of same | |
WO2012038979A3 (en) | A process for preparation of ertapenem | |
CA2922375C (en) | Alpha-tea salt forms: compositions and uses for treating disease | |
MX2013002620A (en) | Novel n-hydroxy-benzamides for the treatment of cancer. | |
WO2014083580A3 (en) | Pharmaceutical compositions of regadenoson | |
WO2014144407A8 (en) | Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof | |
WO2011044375A3 (en) | Apogossypolone derivatives as anticancer agents | |
WO2010023473A3 (en) | Crystalline form of sunitinib and processes for its preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 12 MAY 2018 BY AJ PARK Effective date: 20170310 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 MAY 2019 BY CPA GLOBAL Effective date: 20180329 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 MAY 2020 BY COMPUTER PACKAGES INC Effective date: 20190418 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 MAY 2021 BY COMPUTER PACKAGES INC Effective date: 20200418 |
|
ASS | Change of ownership |
Owner name: MELINTA THERAPEUTICS, INC., US Effective date: 20210414 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 MAY 2022 BY COMPUTER PACKAGES INC Effective date: 20210418 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 MAY 2023 BY COMPUTER PACKAGES INC Effective date: 20220417 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 MAY 2024 BY COMPUTER PACKAGES INC Effective date: 20230417 |